Lubrizol Life Science Health launches novel astaxanthin microencapsulated with spirulina

Photo © iStockphoto.com/Jacob Wackerhausen

Lubrizol Life Science Health (Barcelona, Spain; LLS Health) launched Astagile microcapsules; a sustainable, organic-certified astaxanthin (Haematococcus pluvialis) microencapsulated with spirulina that is designed to promote mental agility and support healthy aging for young and senior adults. LLS Health teamed with Neoalgae Micro Seaweeds Products, SL, an R&D company that specializes in microalgae biotechnology, to create this blend. 

H. Pluvialis is cultivated in a closed greenhouse under rigidly controlled environmental conditions via a two-stage culturing process to ensure it’s free of contaminants or pollutants. Its powder format makes it suitable for many applications such as tablets and capsules, shakes, sport nutrition beverages, and more. 

“This new nootropic is an all-natural formula with superior stability,” said Isabel Gomez, global marketing manager of LLS Health’s Nutraceutical Business, in a press release. “We’ve applied cutting-edge technology to ensure stability of the naturally occurring carotenoids that, coupled with our microencapsulation technology, allows us to draw out the maximum antioxidant capacity and achieve full functional benefits, all while using less of the astaxanthin dose, enabling a more cost-efficient solution for those interested in preserving and enhancing their cognitive function.” Gomez said that microencapsulation stabilizes astaxanthin and the use of spirulina further enhances the antioxidant properties of astaxanthin, amplifying the benefits of both compounds. 

According to the company, in vitro studies attest to its high stability and superior antioxidant traits, and recent studies showed Astagile boosts memory performance, cognition, and learning capabilities and provides antioxidant and anti-inflammatory protection to the brain. 

“Astaxanthin’s antioxidant activity is due to its highly conjugated structure,” said David Padró, manager of the nutraceuticals business of LLS Health, in a press release. “However, it also makes it prone to instability and subsequent degradation during the manufacturing and storage process. This can lead to loss of biological activity, significantly limiting its use in nutraceutical applications.”